Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1323 studies found for:    menstruation OR menstrual cycle AND NICHD
Show Display Options
Rank Status Study
21 Completed Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual Cycle
Condition: Abnormal Menstrual Cycle
Intervention: Drug: dexmedetomidine
22 Recruiting Menstrual Cycle on Injection Pain of Rocuronium
Condition: Pain, Menstrual
Intervention: Drug: Rocuronium 0,6mg/kg
23 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Elagolix + Estradiol/Norethindrone Acetate
24 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Estradiol/Norethindrone Acetate
25 Completed
Has Results
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
Condition: Menorrhagia
Intervention: Drug: Tranexamic acid
26 Completed Vitamin K Injections for the Treatment of Painful Menstruation
Condition: Dysmenorrhea
Intervention: Procedure: Acupuncture point injection of vitamin K
27 Unknown  Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
Conditions: Heavy Menstrual Bleeding;   Menorrhagia;   Hypermenorrhea
Interventions: Drug: Norethindrone acetate pretreatment;   Other: No pretreatment
28 Completed
Has Results
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women
Condition: Healthy
Interventions: Drug: tenofovir;   Drug: emtricitabine;   Drug: atazanavir;   Drug: ritonavir
29 Completed FLOW-Finding Lasting Options for Women
Condition: Menstruation
Intervention: Device: Diva Cup TM
30 Active, not recruiting Menstrual Cycle Maintenance and Quality of Life: A Prospective Study
Conditions: Amenorrhea;   Menstrual Cycle;   Breast Cancer
Intervention: Other: Questionnaire
31 Completed Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
Condition: Menstrual Migraine (MM) Headaches
Interventions: Drug: Frovatriptan;   Drug: Usual Care
32 Not yet recruiting Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
Conditions: Improve Quality of Life;   Heavy Menstrual Bleeding
Interventions: Drug: combined contraceptive pills (microcept);   Drug: medroxyprogesterone acetate (progest);   Drug: mefenamic acid (ponstan forte)
33 Terminated Frovatriptan and Menstrual Migraine
Conditions: Frovatriptan;   Menstrual Migraine
34 Terminated
Has Results
Study to Evaluate Menses Induction in Women Administered Proellex
Condition: Amenorrhea
Interventions: Drug: Placebo;   Drug: Proellex
35 Completed Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh
Condition: Menstrual Regulation
Intervention: Drug: Mifepristone and misoprostol
36 Completed A Pilot Study of Acupoint Injection for Primary Dysmenorrhea
Conditions: Dysmenorrhea;   Pain, Menstrual
Interventions: Other: Vitamin K acupoint injection;   Other: Saline Injection
37 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
38 Unknown  Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
Conditions: Menstrual Migraines;   Menstrual Bleeding;   Menstrual Spotting
Intervention: Drug: Estradiol or Placebo
39 Completed
Has Results
The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle
Conditions: Ovulation (Follicular Rupture Yes/no);   Menstrual Cycles (Total Length, Bleeding Days);   Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)
Interventions: Drug: Celebrex;   Drug: Placebo
40 Unknown  Protocol for the Determination of Menstrual Losses in Healthy Women With Apparently Normal Cycles
Conditions: Validate QUEM Method;   Quantitative Determination of Menses

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years